000 01142 a2200325 4500
005 20250517142142.0
264 0 _c20180621
008 201806s 0 0 eng d
022 _a1872-9452
024 7 _a10.1016/j.mam.2017.02.003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFredman, Gabrielle
245 0 0 _aSpecialized pro-resolving mediators in cardiovascular diseases.
_h[electronic resource]
260 _bMolecular aspects of medicine
_cDec 2017
300 _a65-71 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAtherosclerosis
_xdrug therapy
650 0 4 _aCardiovascular Diseases
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInflammation Mediators
_xmetabolism
650 0 4 _aIschemia
_xetiology
650 0 4 _aMyocardial Infarction
_xdrug therapy
650 0 4 _aPeptides
_xmetabolism
650 0 4 _aPlatelet Activation
650 0 4 _aThrombosis
_xetiology
700 1 _aSpite, Matthew
773 0 _tMolecular aspects of medicine
_gvol. 58
_gp. 65-71
856 4 0 _uhttps://doi.org/10.1016/j.mam.2017.02.003
_zAvailable from publisher's website
999 _c26933642
_d26933642